Soleus Capital Management’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Soleus Capital Management’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-746,622	Closed	-$46.4M	–	102
2023 Q4	$46.4M	Buy	746,622 +295,459	+65%	+$7.34M	5.15%	4
2023 Q3	$10M	Buy	+451,163	New	+$9.47M	0.92%	36

Soleus Capital Management's RYZB Position: Q1 2024 in Review

Soleus Capital Management sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 746,622 shares — an estimated $46.4M sold.

Soleus Capital Management first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $46.4M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Soleus Capital Management reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Soleus Capital Management sold 746,622 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $46.4M.
Soleus Capital Management first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Soleus Capital Management's RayzeBio, Inc. Common Stock position peaked at $46.4M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Soleus Capital Management's 13F filing for Q1 2024, filed 15 May 2024.